88IV - PR Newswire Asia's news


Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity - This trial marks the fourth Phase I peptide study for Ascletis this year. ... 2026-09-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure IRVINE, Calif. , Sept. 8, 2026 /PRNewswire/ -- PeproMene Bio, Inc. today announced the publication in The Lancet , one of the world's leading medical journals, of results from its Phase 1 clinical ... 2026-09-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
/C O R R E C T I O N -- GCCL/ In the news release, "GCCL Strengthens Asia-Pacific Presence at Asia Bio Partnering Forum 2026," issued on September 8, 2026 by GCCL over PR Newswire, we are advised by the company that the name ... 2026-09-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PT Prodia Diacro Laboratories Receives Frost & Sullivan's 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellence Prodia the CRO is recognized for its reliable, integrated clinical research ecosystem, customer-centric delivery model, and commitment to quality, innovation, and long-term sponsor value across Southeast ... 2026-09-08T Biotechnology Health Care/Hospital
Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansion CHUNCHEON, South Korea , Sept. 8, 2026 /PRNewswire/ ... 2026-09-08T Biotechnology Cosmetics & Personal Care
Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia. ... 2026-09-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ministry of Food and Drug Safety of Korea, Successfully Concludes 'GBC 2026,' Marking a Great Leap in Bio – 5,600 participants from 19 countries discuss global bio innovation and the path forward – ... 2026-09-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nature Biotechnology \| Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks First-in-Class Evaluation of an AI-Driven Candidate : This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models ... 2026-09-07T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities YANTAI, China , Sept. 7, 2026 /PRNewswire/ -- CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certification ... 2026-09-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform MELBOURNE, Australia , Sept. 7, 2026 /PRNewswire/ -- Nutromics, a Melbourne-based startup leading the frontier of DNA-based sensing, has announced the appointment of Professor Kevin W. Plaxco as Chief ... 2026-09-07T Biotechnology Health Care/Hospital Medical Equipment

PR Newswire Asia's news > Biotechnology